NC-Based PPD Sold

Oct 4, 2011

North Carolina’s clinical trials industry is seeing a major shift.  The latest example is the purchase of Wilmington-based P-P-D.

The federal government has awarded drug maker Chimerix a nearly $25 million grant to develop an anti-viral drug for smallpox.

The Durham-based company’s lead candidate is a drug called CMX001. Chimerix President and CEO Kenneth Moch says the government wants the treatment ready in case of a smallpox outbreak as the result of a bioterrorist attack.